Paurus Irani, MD

Senior Director – Global Medical Affairs
Pfizer United Kingdom, United Kingdom

Disclosure(s): Pfizer, Inc.: Employee, Stocks/Bonds (Private Company)

Poster(s):

• (P-1151) The in vitro activity of ceftazidime-avibactam against Enterobacterales isolates collected in Latin America as a part of the ATLAS Global Surveillance Program 2019-2023, by β-lactamase carriage
  Tuesday, October 21, 2025

  12:15 PM - 1:30 PM US ET

• (P-1338) In vitro activity of ceftazidime-avibactam and comparator agents against Pseudomonas aeruginosa stratified by infection source and ward: ATLAS Global Surveillance Program, 2019-2023
  Tuesday, October 21, 2025

  12:15 PM - 1:30 PM US ET

• (P-1339) In vitro activity of ceftazidime-avibactam and comparators against Pseudomonas aeruginosa collected worldwide stratified by age group, ATLAS Global Surveillance Program, 2019-2023
  Tuesday, October 21, 2025

  12:15 PM - 1:30 PM US ET